Cholib 145 mg/20 mg
Cholib 145 mg/20 mg is a medicine authorised by Swissmedic under authorisation number 65222. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 25 August 2014 and the authorisation is valid without a time limit. ATC code C10BA04 places the medicine in the group Lipid modifying agents.
| Authorisation number | 65222 |
|---|---|
| Name | Cholib 145 mg/20 mg |
| Full name | Cholib 145 mg/20 mg, Filmtabletten |
| Authorisation holder | Viatris Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C10BA04 |
| First authorisation | 25 August 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Cholib 145 mg/20 mg, Filmtabletten | B | 25 August 2014 |
| 2 | Cholib 145 mg/40 mg, Filmtabletten | B | 25 August 2014 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | C10BA04 | 07.12.0. | B |
| 2 | 90 | Tablette(n) | C10BA04 | 07.12.0. | B |
| 3 | 30 | Tablette(n) | C10BA04 | 07.12.0. | B |
| 4 | 90 | Tablette(n) | C10BA04 | 07.12.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Cholib 145 mg/20 mg authorised in Switzerland?
Yes. Cholib 145 mg/20 mg is authorised by Swissmedic under authorisation number 65222, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Cholib 145 mg/20 mg have?
Cholib 145 mg/20 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Cholib 145 mg/20 mg?
The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.